Yeast screening platform identifies FDA-approved drugs that reduce Aβ oligomerization

March 3, 2016

This article comments on work published by Park et al. (Microbial Cell, 2016), which discovered a number of small molecules capable of modulating Aβ aggregation in a yeast model.